I bought a few today only because it was moving and I was trying to catch the wave and ride it to profit. Since then I have looked into the company a little more and this one could be worth putting on radar. From what I can find people are hoping to receive word from the FDA in the next several days on a filter NEPH has designed for blood. There is also a June decision coming so the company has several irons in the fire.
52 week low = .01 52 week high = .97
************************************************** ************************************************** ************************************************** ************************
http://www.nephros.com/index.html
Nephros, Inc. was founded in 1997 by Columbia University health
for the End Stage Renal Disease (ESRD) patient, while addressing
the critical needs of the care provider. The Company has developed
the most effective ESRD therapy available worldwide, offering unique
and proprietary technologies that dramatically improve clinical efficacy.
Nephros technologies also remove a range of harmful substances not
currently removed by existing dialysis methods; addressed specifically
are substances known collectively as middle molecules, due to their
molecular weight, that contribute to such conditions as carpal tunnel
syndrome, dialysis related amyloidosis, and degenerative bone disease
in the ESRD patient.
Founded in 1997 to address current voids in ESRD treatment:
Stale Methodologies
Cost and Reimbursement Issues
Quality of Care Issues
Nephros technology focus:
Unique and cost-effective proprietary technologies
Marked improvements in treatment efficacy per unit time
Platforms: easy to use and maintain
Technology that integrates well with existing mfg and clinical
Neph ... Nephros Inc
Linear Mode
